Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPPH with PDT vs Surgery for Oral Cavity Squamous Cell Carcinoma
NCT02119728Phase 2Withdrawn
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Primary completion
- Jan 2017
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in squamous cell carcinoma of the oral cavity (OSCC) comparing Arm I (standard of care surgery) with Arm II (HPPH, photodynamic therapy) (2 arms). Primary endpoints: Objective tumor response at 3 months and Changes in quality of life up to 5 years. Status: withdrawn.
02
Drugs
hpph
03
Conditions
squamous cell carcinoma of the oral cavity (OSCC)
Beyond the preview
Go deeper on NCT02119728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02119728.